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Coilin is considered the Cajal body (CB) marker protein. In this report, we investigated the role of
coilin in the DNA damage response and found that coilin reduction correlated with signiﬁcantly
increased levels of soluble cH2AX in etoposide treated U2OS cells. Additionally, coilin levels inﬂu-
enced the proliferation rate and cell cycle distribution of cells exposed to etoposide. Moreover, coilin
overexpression inhibited nucleolar localization of endogenous coilin in etoposide treated U2OS
cells. Collectively, these data provide additional evidence for coilin and CBs in the DNA damage
response.
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Coilin is considered the Cajal body (CB) marker protein. CBs are
subnuclear domains that participate in small nuclear ribonucleo-
protein (snRNP) biogenesis and are most often found in transcrip-
tionally active cells such as neuronal and cancer cells [1–4]. Coilin
knockout and knockdown experiments have demonstrated that
this protein is required for CB formation, optimal cellular prolifer-
ation, and viability (in mouse and zebraﬁsh but not in Drosophila)
[5–10]. Considering that coilin has been shown to interact with
several factors within CBs, including itself [11], it is possible that
coilin plays an important role in the initial formation of this nucle-
ar structure. Moreover, our recent work showing that coilin has
both nucleic acid binding and RNase activities indicates that this
protein may participate more directly in snRNA biogenesis than
previously believed [12]. Mutational analysis of suspected and
known coilin phosphorylation sites demonstrates that this modiﬁ-
cation impacts cellular proliferation and CB formation as well as
coilin localization and stability [13–16].
Deciphering the underlying mechanisms for CB protein modiﬁ-
cation is an active area of investigation, but it is logical to conclude
that the CB is responsive to a variety of cellular signals in order to
coordinate snRNP biogenesis with splicing needs. One of these sig-
nals is DNA damage. A variety of different methods for inducingchemical Societies. Published by E
ochemistry, The University of
ckson, MS 39216-4505, USA.DNA damage, such as herpes simplex type 1 infection, UV-C and
c-irradiation exposure, or treatment with the chemotherapeutic
drug cisplatin, have been shown to disrupt CBs and redistribute
coilin [16–18]. In this present study, we have extended our analy-
sis into the role of coilin in the DNA damage response by utilizing
the p53 positive U2OS cell line treated with etoposide. We demon-
strate here that depletion of coilin induces soluble cH2AX levels in
etoposide treated U2OS cells. Changes in coilin levels correlate
with alterations in cell proliferation rate in etoposide treated cells.
Also, we found that coilin overexpression during treatment in-
creases the percent of cells in the S and G2/M phases of the cell cy-
cle. Collectively, these data further indicate a role for coilin and CBs
in the DNA damage response.2. Materials and methods
2.1. Cell culture, transfections, immunoblotting and
immunoﬂuorescence
Human osteosarcoma cells (U2OS), a gift from Dr. Luis Martinez
(The University of Mississippi Medical Center, Jackson, MS), were
obtained from the American Type Culture Collection (Manassas,
VA). These cells were cultured using the conditions described pre-
viously [19]. GFP-tagged coilin was previously described [14,20].
DNA and duplex siRNA transfections were performed using Fu-
GENE HD (Promega, Madison, WI) or Lipofectamine 2000 (Invitro-
gen, Carlsbad, CA), respectively, according to the manufacturer’s
speciﬁcations and as previously described [10,16]. For coilinlsevier B.V. All rights reserved.
Fig. 1. Coilin reduction induces soluble cH2AX levels upon etoposide treatment. (A)
U2OS cells were transfected with coilin siRNA or control siRNA for 24 h, then
untreated or treated with etoposide for an additional 16 h. Cell lysates were
western blotted and probed with anti-coilin (top panel), anti-cH2AX (middle panel)
and anti-b tubulin antibodies (lower panel). b tubulin serves as a loading control.
(B) Quantitative analysis of cH2AX relative to b-tubulin levels. The ratio of cH2AX
relative to b-tubulin from treated control and coilin siRNA transfected cells were
normalized to the ratio obtained from treated cells not transfected with siRNA. The
increased relative cH2AX level in coilin siRNA transfected cells was statistically
signiﬁcant (⁄, p = 0.02, n = 3) compared to control siRNA cH2AX levels.
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ployed (N004645.12.4 and the coilin 2 duplex previously published
[10,16]). The duplex siRNAs were obtained from Integrated DNA
Technologies (Coralville, Iowa). Cells were treated with 20 lM eto-
poside for 16 h unless otherwise stated. Immunoﬂuorescence,
Western blotting and image acquisition were carried out as de-
scribed previously [19]. The following antibodies were used: rabbit
polyclonal anti coilin (H300, Santa Cruz Biotechnology, Santa Cruz,
CA), rabbit polyclonal anti-cH2AX (Bethyl, Montgomery, TX),
mouse monoclonal anti-b-tubulin (Sigma–Aldrich, St. Louis, MO),
mouse monoclonal anti-ﬁbrillarin [16] and mouse monoclonal
anti-GFP (Roche, Mannheim, Germany).
2.2. Soluble cH2AX protein isolation
Soluble cH2AX proteins were isolated as described previously
[21] with a few modiﬁcations. Brieﬂy, U2OS cells were lysed in
500 ll buffer A (20 mM HEPES, pH 7.9, 0.5 mM DTT, 1 mM PMSF,
1.5 mM MgCl2, 0.1% Triton and 1 M NaCl) and incubated at 4 C
for 40 min and then centrifuged at 100,000 g (TL-100 Ultracentri-
fuge, Beckman) for 20 min. Total cH2AX proteins were obtained
by sonication in RIPA buffer (50 mM Tris–HCl pH 7.6, 150 mM
NaCl, 1% NP-40, 0.25% sodium deoxycholate, 0.1% SDS, 1 mM
EDTA). Supernatants were subjected to SDS–PAGE, Western blot-
ting and detection of proteins using the antibodies described
above. Protein signals were quantiﬁed with Quantity One software
using a Chemidoc XRS system (Biorad, Hercules, CA).
2.3. Propidium iodide staining, FACS analysis and proliferation assays
U2OS cells transfected with empty GFP vector or GFP-coilin for
24 h were untreated or treated with etoposide for an additional
16 h. The cells were then harvested and washed with PBS by cen-
trifuging at 1500 rpm for 3 min. Each sample for FACS analysis
had 0.5  106 cells. The cells were ﬁxed with ice cold 70% ethanol
for 30 min and washed with PBS. Cell pellets were then dissolved
in 350 ll PBS and incubated with 30 ll of Ribonuclease A
(10 mg/ml) (Sigma, St Louis, MO) for 5 min at room temperature.
The cells were stained with 150 ll of Propidium Iodide (250 lg/
ml) for 15 min at room temperature. The cell cycle distribution of
GFP and GFP-coilin expressing cells was analyzed using the Gallios
Flow Cytometer (Beckman Coulter) with data analysis by Kaluza
software (version 1.1). For proliferation studies, U2OS cells were
transfected with siRNA or plasmid DNA for 24 h, followed by seed-
ing into a 96-well plate with 5000 cells per well [16]. Cells were
untreated or etoposide treated the same day as seeding. 48 h post
transfection, cell number was estimated using the cell titer blue re-
agent (Promega) as described in the manufacturer’s protocol. The
cells were read using the 490/540 ﬁlter set on FLx800 Spectropho-
tometer (BioTek, Winooski, VT).
3. Results
3.1. Coilin knockdown induces soluble cH2AX levels in etoposide
treated U2OS cells
Previous studies have demonstrated that coilin localization is
altered by DNA damage [17,18,22,16]. To explore further the role
of coilin in the DNA damage response, we evaluated whether coilin
levels inﬂuence the formation of cH2AX in etoposide treated U2OS
cells. Etoposide is an anti-cancer drug that forms a tertiary com-
plex with topoisomerase II, thus promoting double strand breaks
and apoptosis [23]. cH2AX is not detected in untreated cells, but
is found in lysate generated from etoposide treated cells
(Fig. 1A). We examined two pools of cH2AX; the soluble fraction
obtained by salt extraction and the total fraction obtained bysonication. The relative level of soluble cH2AX in cells subject to
control siRNA transfection followed by etoposide treatment did
not signiﬁcantly differ compared to that observed in non-transfec-
ted etoposide treated cells. However, soluble cH2AX levels relative
to tubulin were signiﬁcantly higher in coilin siRNA etoposide trea-
ted cells compared to control siRNA etoposide treated cells
(p = 0.02, n = 3, Fig. 1, quantitative analysis in Fig. 1B). Coilin knock-
down in the absence of etoposide was not sufﬁcient to trigger the
formation of cH2AX (Supplementary Fig. 1A). Moreover, coilin
reduction did not impact total cH2AX levels in the presence of eto-
poside (Supplementary Fig. 1A).
3.2. Coilin levels impact proliferation rate in cells exposed to etoposide
Previous studies have shown that coilin reduction slows cellular
proliferation and attenuates decreases in proliferation associated
with cisplatin treatment [9,10,16]. To examine if a similar pheno-
type is observed when using etoposide, we conducted proliferation
assays on untreated and etoposide treated U2OS cells transfected
with control or coilin siRNA (Fig. 2A). As expected, etoposide treat-
ment reduces control siRNA transfected cell number (control KD+)
by approximately 65% compared to untreated control KD (control
KD). In contrast, etoposide treated coilin siRNA transfected cell
number (coilin KD+) is reduced by approximately 43% compared
to untreated coilin siRNA (coilin KD). Therefore, coilin knockdown
diminishes the effect of etoposide and increases cell number by
22% in treated U2OS cells. In untreated cells, coilin reduction de-
creases cell number by approximately 35% (coilin KD compared
Fig. 2. Coilin impacts cell proliferation rates in etoposide treated U2OS cells. (A)
Proliferation assay on U2OS cells transfected with control siRNA (control KD) or
coilin siRNA (coilin KD). Data were normalized to that obtained for the untreated
control KD condition (⁄ = p < 0.05 versus control KD, # = p < 0.05 versus control KD+,
n = at least 12 for each condition). (B) Proliferation assay on U2OS cells transfected
with GFP or GFP-coilin and treated with etoposide (+) or untreated, normalized to
the untreated GFP (GFP-coilin) transfected condition. Treated cells expressing GFP-
coilin were signiﬁcantly reduced in their proliferation compared to untreated or
treated cells expressing GFP alone (⁄p = < 0.05 versus GFP, # = p < 0.05 versus GFP+,
n = at least 12 for each condition).
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coilin reduction attenuated the negative effect of etoposide on pro-
liferation compared to control siRNA, we next tested if coilin over-
expression would exacerbate the decrease in proliferation as a
consequence of etoposide treatment. For these studies, U2OS cells
were transfected with empty GFP or GFP-coilin vectors and cell
numbers were determined after treatment with etoposide or no
treatment (Fig. 2B). In cells expressing GFP, cell number decreased
by approximately 60% upon treatment (GFP + compared to GFP).
GFP-coilin expression resulted in a more pronounced effect of eto-
poside, reducing cell number by approximately 75% after etoposide
treatment (GFP-coilin +) compared to that obtained in the non-
treated GFP-coilin expression condition (GFP-coilin), and this dif-
ference is statistically signiﬁcant. The level of total or soluble
cH2AX did not signiﬁcantly change in GFP-coilin expressing cells
compared to control (Supplementary Figs. 1B and 1C). It should
be pointed out that the conditions used here (20 mM etoposide
for 16 h) are not sufﬁcient to induce apoptosis, as assessed by
PARP1 cleavage (Supplementary Fig. 1D) and Annexin V staining
(our unpublished observations). Collectively, these results indicate
that coilin levels alter the sensitivity of cells to etoposide.
3.3. Overexpression of coilin in the presence of etoposide increases the
distribution of cells in S and G2/M phases of the cell cycle
As described above, ectopically expressed coilin signiﬁcantly re-
duces cell proliferation in etoposide treated U2OS cells (Fig. 2B). To
examine if these cells have an altered cell cycle distribution, we
conducted FACS analysis strictly on cells expressing GFP orGFP-coilin. Cell cycle distribution for each treatment is shown in
Fig. 3. In untreated cells, GFP-coilin expression did not signiﬁcantly
change cell cycle distribution relative to control cells expressing
GFP only. As expected, etoposide treatment of cells expressing
GFP resulted in a characteristic decrease in the percent of cells in
G1 and increase in the number of cells in S and G2/M. Interestingly,
overexpression of coilin in treated cells further decreased the per-
cent of cells in G1 below that found for GFP expressing cells and
correspondingly increased cell distribution in S and G2/M. The dif-
ferences in cell cycle distribution in the presence of etoposide be-
tween GFP and GFP-coilin expressing cells are statistically
signiﬁcant. These results show that reduced proliferation in the
presence of etoposide as a consequence of coilin overexpression
may be attributed to the accumulation of cells in S and G2/M. No
signiﬁcant changes in cell cycle distribution were observed in eto-
poside treated coilin knockdown cells (Supplementary Fig. 2).
3.4. Exogenous coilin inhibits etoposide-induced nucleolar
accumulation of endogenous coilin
We have reported that DNA damaging agents redistribute coilin
to the nucleolus, and depleted coilin levels increase cell viability in
cisplatin treated cells [16]. We hypothesized that alteration of coi-
lin levels would disrupt nucleolar redistribution of coilin in re-
sponse to DNA damage. In a given ﬁeld of untreated U2OS cells,
three different coilin phenotypes can be observed (n = 100,
Fig. 4A, upper panel). The majority of cells (52%) have at least 1
CB, other cells display only nucleoplasmic coilin (38%), and a size-
able fraction contain nucleolar coilin (10%). Upon exposure to eto-
poside, the number of cells with CBs is decreased (14%), but the
percent of cells with nucleoplasmic (50%) or nucleolar localization
(36%), veriﬁed by co-staining with ﬁbrillarin, is increased (n = 100,
Fig. 4AB,). Time course experiments do not detect coilin accumula-
tion at sites of DNA damage after etoposide treatment. In order to
test if coilin overexpression alters nucleolar relocalization of
endogenous coilin upon etoposide treatment, U2OS cells were
transfected with GFP or GFP-coilin and treated or untreated
(Fig. 4C). Treated U2OS cells have the expected nucleolar localiza-
tion of endogenous coilin (double arrowhead) in GFP transfected or
non-transfected cells. However, GFP-coilin expression in the pres-
ence of etoposide results in different phenotypes for the endoge-
nous coilin based on the expression level of GFP-coilin (Fig. 4C,
lower panels). In treated cells with faintly detected GFP-coilin,
both endogenous coilin and GFP-coilin display nucleolar accumu-
lation (Fig. 4C, middle panel, treated, low expression). Note that
since the antibody used here reacts with both GFP-coilin and
endogenous coilin, it is assumed that the coilin signal represents
both endogenous coilin and GFP-coilin. In contrast to that observed
in etoposide-treated low expressing cells, treated cells displaying
medium expression show predominantly nucleoplasmic localiza-
tion of GFP-coilin and lack signiﬁcant nucleolar accumulation
(Fig. 4C, lower panel). These results demonstrate that exogenous
coilin can act in a dominant negative manner to inhibit the nucle-
olar localization of endogenous coilin in the presence of etoposide.
4. Discussion
To extend previous studies demonstrating a relationship be-
tween coilin and the DNA damage response [16–18,22], we con-
ducted experiments designed to ascertain if coilin modulates
proteins involved in this pathway. For these studies, we employed
the U2OS cell line, which contains a functional p53 response to
DNA damage [24] such as that caused by etoposide. Surprisingly,
soluble cH2AX levels were increased fourfold in coilin siRNA com-
pared to control siRNA transfected cells treated with etoposide
(Fig. 1). A similar increase in cH2AX levels has been observed upon
Fig. 3. Transiently transfected coilin increases the percent of cells in S and G2/M after etoposide treatment. (A) U2OS cells expressing GFP or GFP-coilin were untreated or
subjected to etoposide treatment (+) 24 h after transfection, followed by FACS analysis. Cell cycle distribution was conducted only on cells expressing GFP or GFP-coilin. (B)
The bar graph represents the mean percentage of each cell cycle phase ± standard error about the mean from three independently conducted experiments. ⁄ = p < 0.05 versus
G1, S and G2/M phases of treated GFP expressing cells.
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tein that partially accumulates in CBs [25]. The role of chroma-
tin-associated cH2AX in orchestrating the DNA repair proteins at
the site of DNA damage is well-established [26–29]. In contrast,
soluble cH2AX function is less well understood, but is reported
to have pro-apoptotic properties [24]. Since coilin reduction in-
creased the amount of soluble cH2AX in etoposide treated cells,
we suspect that coilin negatively regulates the production of
cH2AX and/or positively regulates the factors that subsequently
acetylate and ubiquitinate cH2AX. Thus, when coilin is reduced,
the level of soluble cH2AX is increased. It is important to note that
coilin does not accumulate at sites of DNA damage, nor does coilin
depletion alter the number of cH2AX repair foci (analyzed at 3 and
16 hrs post-etoposide treatment) or level of DNA damage as ac-cessed via comet assay (our unpublished results). These ﬁndings
indicate that coilin impacts soluble cH2AX levels, but does not par-
ticipate in its initial formation. The exact mechanism(s) leading to
the release of cH2AX from damaged chromatin is unknown. How-
ever, it is known that cH2AX must be acetylated prior to ubiquiti-
nation by the TIP60-UBC13 complex, which leads to the release of
cH2AX from chromatin [30]. Future studies will more clearly elu-
cidate the mechanism by which DNA damage induces soluble
cH2AX, and the role of coilin in this process.
We show here that coilin knockdown signiﬁcantly decreased
the proliferation rate in untreated U2OS cells (Fig. 2A). These re-
sults are in agreement with previous reports showing that coilin
knockdown reduces cell viability in HeLa cells [9,10,20,11]. Para-
doxically, coilin knockdown signiﬁcantly attenuates the reduction
Fig. 4. Coilin levels inﬂuence nucleolar accumulation in etoposide treated U2OS cells. (A) Distribution of coilin (red) in untreated and etoposide treated U2OS cells. DAPI
staining was used to detect the nucleus (blue). In untreated cells (upper panel), an arrow indicates a cell with nucleoplasmic coilin but lacking CB, arrowheads denote coilin in
CBs, and double arrowheads show nucleolar coilin accumulation. In etoposide treated cells, the percent of cells with nucleolar coilin accumulation (double arrowhead) is
increased compared to that found in untreated cells. Scale bars = 10 lm. (B) Untreated and etoposide treated U2OS cells were co-stained with antibodies to detect coilin
(green) and ﬁbrillarin (red). Double arrowheads mark nucleolar accumulations, and arrowheads indicate CBs. (C) Over expression of GFP-coilin suppresses the nucleolar
accumulation of endogenous coilin in etoposide treated U2OS cells. Cells were transfected with GFP or GFP-coilin and 24 h post transfection cells were treated with etoposide
or left untreated, and then stained to detect coilin (red) or GFP/GFP-coilin (green). DAPI (blue) was used to detect the nucleus. Arrowheads denote CBs and double arrowheads
indicate nucleolar coilin. For untreated cells transfected with the empty GFP vector, arrows indicate two cells, one of which is expressing GFP, which have nucleoplasmic
coilin but lack CBs. For untreated cells transfected with GFP-coilin vector, arrows also indicate two cells, one of which is expressing GFP-coilin. Treated cells expressing low
and medium levels of GFP-coilin are shown. Scale bars = 10 lm.
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words, in the presence of etoposide, coilin knockdown increases
cell number over that found with coilin present (Fig. 2A). This same
phenomenon has been observed using another type of DNA
damaging agent (cisplatin) on other cell lines (HeLa, Saos2 and
WI-38) [16]. We speculate that diminished snRNP resources as a
consequence of abolished CBs cause the observed decrease in pro-
liferation rate in coilin knockdown untreated cells. In contrast, we
hypothesize that cell proliferation is not as drastically reduced in
coilin knockdown cells because the nucleoplasmic function of coi-
lin may responsible for the promotion of cell cycle arrest or death
in response to DNA damage. Since the normal response for endog-
enous coilin in the presence of DNA damage induced by etoposide,
cisplatin or c-irradiation is to translocate to the nucleolus (Fig. 4A
and B, [16]), we speculate that nucleolar coilin participates in the
arrest of the cell cycle, possibly via reduction of snRNP biogenesis
and RNA pol I activity, until such time that the DNA has been re-
paired. We have previously shown that the nucleolar accumulation
of coilin caused by another DNA damaging agent (cisplatin) is cor-
related with reductions in pol I activity [16]. Hence, it is possible
that the nucleolar accumulation of coilin as a consequence of eto-
poside treatment also impacts pol I activity. Alternatively or addi-
tionally, we have shown that coilin has in vitro RNA binding and
RNase activity [12], thus it is also possible that nucleolar coilin dis-
rupts rRNA processing or stability.
In summary, the data obtained from this and other studies indi-
cate that the localization of coilin may inﬂuence cell cycle progres-
sion. We hypothesize that coilin in the CB promotes proliferation
by ensuring that adequate snRNP resources are present. Although
far from proven, we further hypothesize that nucleolar coilin in-
duced by the presence of DNA damaging agents arrests the cell cy-
cle, possibly by inhibiting RNA pol I or rRNA processing.Nucleoplasmic coilin, in contrast, may promote cell death in the
presence of DNA damage by inappropriately increasing progres-
sion through the cell cycle. Current and future work should more
precisely deﬁne the role of coilin in this response and clarify the
function of coilin in the nucleoplasm, nucleolus and CB.
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